Mesoblast reported $718.15M in Market Capitalization this December of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Clinuvel Pharmaceuticals Ltd CUV:AU AUD 733.74M 610.71M
Cochlear COH:AU AUD 13.07B 1.15B
CSL CSL:AU USD 129.61B 9.57B
Opthea Ltd OPT:AU USD 387.37M 68.39M
Pacific Edge PEB:NZ NZD 1.08B 180.97M
Paradigm Biopharmaceuticals Ltd PAR:AU AUD 219.63M 209.39M
PYC Therapeutics Ltd PYC:AU AUD 206.76M 222.66M
Ramsay Health Care RHC:AU AUD 16.76B 398.25M
Sonic Healthcare SHL:AU AUD 15.85B 6.52B
Starpharma Holdings Ltd SPL:AU AUD 302.25M 242.7M
Telix Pharmaceuticals Ltd TLX:AU AUD 1.42B 792.34M